DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Thyroid cancer	R-HSA-9700206	map05216	ceftazidime	5280953	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	ceftazidime	5280953	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	adrenosterone	5951	drug-path
Olfactory transduction	R-HSA-9751605	map04740	adrenosterone	5951	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	adrenosterone	5951	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	adrenosterone	5951	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	adrenosterone	5951	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	adrenosterone	5951	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	adrenosterone	5951	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	adrenosterone	5951	drug-path
Bladder cancer	R-HSA-9700206	map05219	adrenosterone	5951	drug-path
Asthma	R-HSA-444620	map05310	adrenosterone	5951	drug-path
Allograft rejection	R-HSA-9679028	map05330	adrenosterone	5951	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	adrenosterone	5951	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	oxyphenbutazone	4641	drug-path
Olfactory transduction	R-HSA-9751605	map04740	oxyphenbutazone	4641	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	oxyphenbutazone	4641	drug-path
Homologous recombination	R-HSA-5685942	map03440	oxyphenbutazone	4641	drug-path
Shigellosis	0	map05131	oxyphenbutazone	4641	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	oxyphenbutazone	4641	drug-path